Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

During the Trading Day
11.18 -0.07 / -0.62%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.18 0.00 / 0.00%
Volume: 64.2K
Health Technology
Pharmaceuticals: Other

Company Description

Ironwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. It discovers, develops and intends to commercialize differentiated medicines that improve patient's lives. Its product candidate is linaclotide, a guanylate cyclase type-C agonist being developed for the treatment of patients with irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook, Jr. and Gina Bornino Miller on January 5, 1998 and is headquartered in Cambridge, MA.

Contact Information

Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge Massachusetts 02142
P:(617) 621-7722
Investor Relations:
(617) 374-5082



Individual stakeholders8.60%
Mutual fund holders63.63%
Other institutional49.16%

Top Executives

Peter M. HechtChief Executive Officer & Director
Thomas GraneyChief Financial Officer & SVP-Corporate Strategy
Brian M. CaliSenior VP-Preclinical, Research & Development
Mark G. CurrieChief Scientific Officer & Senior Vice President
Jeffrey M. JohnstonChief Medical Officer & VP-Clinical Development